85-1437-21　MAP Kinase 2, active, Recombinant, Human (Mitogen-activated Protein Kinase 2, MAPK 2, MAPK2, ERT1, Extracellular Signal-regulated Kinase 2, ERK2, ERK-2, ERK, MAP Kinase Isoform p42, Mitogen-activated Protein Kinase 1, MAP Kinase 1, MAPK 1, MAPK1, p41mapk, p42-MAPK, P42MAPK, PRKM1, PRKM2) discontinued 1ug　M2362-02A

特徴

• Recombinant ERK2 (extracellular signal-regulated kinase) a Mitogen-Activated Protein Kinase, is a highly active form produced by phosphorylation of the purified ERK2/MAPK2 in vitro with MEK1 is a non-glycosylated polypeptide having a molecular mass of 44.6kD.
• Unit Definition:1 U = 1 pmol/min transferred to myelin basic protein at 30ºC
• Dimers and Aggregates:≤ 1% as determined by silver-stained SDS-PAGE gel analysis.
• Biological Activity:Specific activity > 15,000 U/mg
• Storage and Stability:May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：1ug
• Source Antigen：Recombinant, E. coli
• Grade：Highly Purified
• Purity：≥ 95% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain. Chromatographically purified.
• Form：Supplied as a liquid in 50mM Tris-HCL, 150mM NaCl, 1mM DTT, and 50% glycerol, pH 8.5
• Molecular Weight Non Ab：44.6
• EU Commodity Code：30021019
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]